The funding comes from the Personalized Regenerative Immunocompetent Nanotechnology Tissue (PRINT) program at ARPA-H, an ...
Worldwide Clinical Trials, a full-service, global CRO headquartered in Research Triangle Park, has entered into a definitive agreement to acquire Wilmington-based Catalyst Clinical Research, a global ...
Operating under the FDA's 503B pathway, the Apex facility will prioritize the production of generic shortage-listed ...
WEP Clinical (WEP), a global contract research organization (CRO) based in Morrisville, N.C., has acquired Siron Clinical, a ...
A North Carolina startup is working to change that. DwellSafe, whose team works out of Asheville and New York City, has ...
Genentech, considered one of the biotech industry’s founding companies, announced in May 2025 that it planned to build a $700 ...
On January 30, 2026, you can attend the third annual Integrative Symposium of NC State Training Grants, bringing together, in true interdisciplinary fashion, eight NIH-funded T32 programs for a day of ...
Join the UNC School of Medicine for a school-wide event featuring Professor Jose R. Penadès, Chair in Microbiology at Imperial College London and an internationally recognized expert in bacterial ...
Marcel Frenkel, Ph.D., co-founder and CEO of Durham -based drug company Ten63 Therapeutics, never thought he’d be focusing the majority of his time and energy on the fight against cancer. As a fencing ...
Join NCLifeSci for a networking lunch and an engaging conversation around partnerships in the life sciences sector. Tom Adams, Ph.D., CEO and co-founder at Pairwise, Tom Greene, Ph.D., senior director ...
The Organic Commodities and Livestock Conference (OCLC) is a free, one-day conference hosted each March by the Carolina Farm Stewardship Association and NC State University. The event is designed for ...
Novo Nordisk has launched its new Wegovy pill, the first GLP-1 pill approved by the U.S. Food & Drug Administration (FDA) to treat obesity. In December, the FDA approved the once-daily Wegovy pill, ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results